Daiichi Sankyo shares rose sharply after the Japanese drugmaker announced a multibillion dollar deal with Merck to jointly develop and commercialize three.
Asia-Pacific stocks dropped Friday, Oct. 20, with shares in Japan decreasing for the second session and the Hong Kong market down for three consecutive.
Nestle’s real internal growth in the third quarter showed a sequential underlying improvement in volume trends, Citi said, adding the RIG consensus miss was small, and “should leave 2023 consensus expectations pretty much unchanged.”
Asia-Pacific stocks were mixed Wednesday, Oct. 18, Japanese shares climbing for the second session. Hong Kong stocks declined, with the Hang Seng Index down.
By Christian Moess Laursen AstraZeneca said its lung-cancer drug Enhertu has been recommended for approval in the European Union following positive test.